Otonomy, Inc. OTIC Cash Flow

Otonomy, inc. (OTIC)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14
Cash flows from operating activities:
Net loss
-44,454	-44,675	-46,595	-49,102	-50,928	-50,368	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-110,898	-	-105,153	-93,546	-76,414	-61,668	-50,320	-46,386	-44,073	-42,877	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
0	-	-	-	0	-	-	-	-	1,289	1,135	980	839	708	0	0	0	-	-	-	-	-	-	-	-
Depreciation and amortization
-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0
Stock-based compensation
4,808	4,890	6,895	8,014	11,197	12,414	13,154	13,595	12,648	13,661	13,796	13,866	13,601	12,611	11,678	10,577	9,109	7,716	6,118	4,384	2,879	1,692	0	0	0
Accretion of discounts on short-term investments
605	787	824	785	666	506	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	39	0	0	0
Change in fair value of convertible preferred stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,300	0	0	0
Amortization of debt discount
195	189	139	91	44	0	-367	-307	-191	0	0	0	926	-	519	205	51	13	16	15	8	1	0	0	0
Deferred rent
-	-	-	-	-	-103	-122	-838	-1,555	-2,272	-2,464	-1,762	-1,058	-358	-169	-174	-149	-86	-22	41	75	73	0	0	0
Changes in operating assets and liabilities:
Accounts receivable, net
-	-	-	-	-	1	-81	-62	-45	16	39	74	32	91	87	2	146	0	0	0	0	-	-	-	-
Inventory
-	-	-	-	-	-	-	-	-	-	-199	582	891	1,739	1,741	913	614	0	0	0	0	-	-	-	-
Prepaid and other assets
-79	-476	1,039	-752	-209	492	-1,422	-1,767	-2,358	-2,761	-2,613	-2,255	-142	613	483	1,204	-305	2,243	3,367	3,730	3,989	34	0	0	0
Accounts payable
-260	127	-343	1,089	-1,312	68	-215	-582	2,270	-398	985	591	-2,217	-2,158	-998	616	610	1,659	157	-543	-1,099	-309	0	0	0
Accrued expenses
277	1,656	854	1,360	1,571	-166	-1,523	-2,497	-3,875	-5,518	-2,246	-1,264	1,126	3,866	1,859	306	191	1,012	1,370	1,620	888	2,498	0	0	0
Accrued compensation
186	-42	-297	-211	-533	-672	-1,784	-1,395	-1,110	-1,532	-761	-772	113	1,650	2,570	2,642	1,611	2,614	1,062	798	708	331	0	0	0
Right-of-use assets and lease liabilities, net
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating leases
-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-38,562	-36,925	-39,997	-37,621	-39,140	-38,434	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from investing activities:
Deferred product sales, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-95,456	-	-90,313	-79,955	-64,012	-49,896	-44,222	-40,983	-41,457	-35,219	0	0	0
Purchases of short-term investments
55,245	85,004	91,800	104,171	115,135	104,270	103,149	109,859	94,004	129,308	158,847	145,209	313,673	261,242	223,048	214,330	38,270	41,332	43,564	32,921	24,057	16,224	0	0	0
Maturities of short-term investments
109,000	114,000	112,000	119,750	132,250	142,750	149,749	157,266	161,321	199,565	236,195	208,408	179,947	114,371	49,651	43,324	39,049	31,370	20,961	11,308	1,489	0	0	0	0
Purchases of property and equipment
674	700	330	306	458	496	878	921	973	1,259	2,248	2,827	2,878	2,546	2,289	1,931	1,921	2,019	1,252	1,123	788	782	0	0	0
Net cash provided by (used in) investing activities
53,081	28,296	19,870	15,273	16,657	37,984	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from financing activities:
Proceeds from issuance of common stock, net of transaction costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Proceeds from exercise of stock options
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	0	0	0	-	0	0	0
Increase in restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	696	-	0	0	0	-	-	-	-
Net cash provided by investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-136,603	-	-174,991	-172,243	-1,143	-11,981	-24,550	-23,356	-23,281	-16,931	0	0	0
Proceeds from issuance of common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	108,850	108,571	108,571	108,327	80,731	0	0	0	-	-	-	-
Proceeds from exercise of stock options
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Payments of debt issuance costs
0	52	52	52	52	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities
247	195	15,007	15,005	15,081	15,165	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash, cash equivalents and restricted cash
14,766	-8,434	-5,120	-7,343	-7,402	14,715	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of common stock warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	1,480	-	109,158	109,168	109,093	81,426	80,219	186,526	234,721	154,676	0	0	0
Net change in cash, cash equivalents and restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	43,243	-	11,447	122,187	169,983	102,526	0	0	0
Supplemental cash flow disclosures
Cash paid for interest
1,388	1,394	1,053	702	351	4	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosure of non-cash investing activities:
Purchase of property and equipment in accounts payable and accrued expenses
139	76	100	-96	-52	7	-217	262	-2	132	78	379	599	647	289	484	233	286	920	87	299	5	0	0	0